Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Filler for medical plastic surgery and its preparation method and application

A filling and medical technology, applied in medical science, prosthesis, tissue regeneration, etc., can solve the problems of inability to carry out quality control and mass production, difficulty in maintaining the effect for a long time, difficulty in wide application, etc., and achieve suitable mass production , avoid subsequent deformation, and prolong the effect of effectiveness

Active Publication Date: 2020-05-08
武汉奥翔生物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, products such as silica gel, hyaluronic acid (Restylane), botox (Botox), saline bags, autologous fillers, and decellularized tissue are commonly used in medical plastic surgery and beauty industries as fillers to be implanted in the body. Four situations will occur when these substances enter the body : The first case is that it is not integrated with the body and is always in a free state. Silica gel, polymethyl methacrylate (Artecoll), and saline bags belong to this type of product; the second case is that it is effective for a short time and is difficult to last To maintain the effect, such products include hyaluronic acid, botulinum toxin, etc.; the third case is autologous fillers, such as cartilage, adipose tissue, skin and subcutaneous tissue, etc., which mainly use autologous cells and tissues in accordance with the model of tearing apart the east to make up for the west. Operation, plastic surgery can be effective for a long time, but this is a case-by-case treatment, unable to carry out quality control and mass production, it is difficult to widely promote and apply; the fourth situation is that it can be integrated with the body and can last for a long time, but after a period of time , filler liquefaction, obvious side effects, such as allogeneic decellularized tissue (Cymetra), synthetic hydroxyapatite (Radiesse), synthetic collagen, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] This embodiment provides a filler for medical plastic surgery, and its preparation method specifically includes the following steps:

[0038] (1) Put 50 g of degreased and antigen-removed pigskin particles with a particle size of less than 0.25 mm in a 500 ml beaker, add 400 ml of normal saline, and stir magnetically at room temperature (the room temperature in the embodiments of the present invention refers to 23-26 °C, the same below). Stir continuously until the saline can no longer be absorbed. It takes about 4 hours. Filter with a sand core funnel to obtain the swollen material, and measure the volume, which is recorded as 1 volume;

[0039] (2) Take a beaker containing 3 volumes of 0.5% (w / v) human serum albumin solution (normal saline dissolves human serum albumin), and slowly add 1 volume of swelling solution under constant stirring with a magnetic stirrer. Material, continue to stir at room temperature for 2 hours, and filter through a sand core funnel to obtai...

Embodiment 2

[0045]This embodiment provides a filler for medical plastic surgery, and its preparation method specifically includes the following steps:

[0046] (1) Take 50g of defatted and deantigenated pigskin particles with a particle size of about 0.35mm and put them in a 500ml beaker, add 400ml of normal saline, and stir continuously with a magnetic stirrer at room temperature until the normal saline can no longer be absorbed. It takes about 4 hours. Filter with a sand core funnel to obtain the swelling material, and measure the volume, which is recorded as 1 volume;

[0047] (2) Take a beaker containing 3 volumes of 0.5% (w / v) human serum albumin solution (normal saline dissolves human serum albumin), and slowly add 1 volume of swelling solution under constant stirring with a magnetic stirrer. Material, continue to stir at room temperature for 2 hours, and filter through a sand core funnel to obtain the coating material;

[0048] (3) coating material is put into 500ml flask, under t...

Embodiment 3

[0053] This embodiment provides a filler for medical plastic surgery, and its preparation method specifically includes the following steps:

[0054] (1) Put 50g of degreased and antigen-removed pigskin particles with a particle size of less than 0.25mm in a 500ml beaker, add 400ml of normal saline, and stir continuously with a magnetic stirrer at room temperature until the normal saline can no longer be absorbed. It takes about 4 hours. The sand core funnel is filtered to obtain the swelling material, and the volume is measured, which is recorded as 1 volume;

[0055] (2) Take a beaker filled with 3 volumes of 0.2% (w / v) human serum albumin solution (normal saline dissolves human serum albumin), and slowly add 1 volume of swelling solution under constant stirring with a magnetic stirrer. Material, continue to stir at room temperature for 2 hours, and filter through a sand core funnel to obtain the coating material;

[0056] (3) coating material is put into 500ml flask, under ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention provides a filler for medical plastic surgery and a preparation method and application thereof. The preparation method comprises the steps: a swollen biomaterial is wrapped with albumin,and then the albumin is solidified through formaldehyde and glutaraldehyde; and preferably, the preparation method comprises the step that the biomaterial swollen through normal saline is sequentially treated through a human serum albumin solution, a formaldehyde solution, a glutaraldehyde solution and an ethyl alcohol solution. The filler provided by the invention is better than existing frequently-used silica gel, hyaluronic acid, creotoxin, normal saline bag, decellularized tissue and the like, the filler has good compatibility with a human body and can also continuously play a role in plastic surgery, the phenomenon of liquefaction is avoided, and side effects are avoided; and the preparation method is simple and suitable for large-scale production.

Description

technical field [0001] The invention relates to the field of medical plastic surgery, and more specifically, to a filler for medical plastic surgery and its preparation method and application. Background technique [0002] Due to the love of beauty and the development of science and technology, the medical plastic surgery and cosmetology industry has developed rapidly in recent years. The main treatment scope includes trauma, disease, congenital or acquired tissue or organ defects and deformities, and the treatment includes repair and reconstruction. , which is essential to use fillers. [0003] At present, products such as silica gel, hyaluronic acid (Restylane), botox (Botox), saline bags, autologous fillers, and decellularized tissue are commonly used in medical plastic surgery and beauty industries as fillers to be implanted in the body. Four situations will occur when these substances enter the body : The first case is that it is not integrated with the body and is alw...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61L27/22A61L27/24A61L27/20A61L27/36A61L27/50
CPCA61L27/20A61L27/227A61L27/24A61L27/3604A61L27/50A61L2430/34C08L89/00
Inventor 张勇孙理华
Owner 武汉奥翔生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products